Description
Introduction
Lancet is one of the widely used alternative device to obtain the blood samples by performing vein puncture. This device is receiving global recognition and acceptance due to its several convenient characteristics which gives lancets an edge over the traditional methods for vein puncture. Some of the very important features of the lancets are painless vein puncture, easy handling and safety while using. The major applications of the lancets are capillary blood microsampling (mainly for diabetes management to check glucose levels), cholesterol test, HBO and HIV screening test, blood group test, coagulation tests, allergy tests and many other blood based tests. According to FDA, blood lancets were classified in the general controls category in the year 1988, which required minimal regulations. The FDA classified all the types of the lancets in the class I category which was “manual surgical instrument for general use”. The classification of lancets includes, single use only blood lancets with an integral sharps injury prevention feature, single use – only blood lancets without an integral sharps injury prevention feature, multiple use blood lancets for single patient use only, and multiple use blood lancets for multiple patient use. A large number of lancet manufacturers are from developing Asian countries such as China, India, Japan and Republic of Korea mainly because of the low labour cost and low R&D cost. China being one of the highly populated and technologically advanced developing countries, has a major number of lancets manufacturers. Some of the renowned Chinese Lancet manufacturers are Guangzhou Improve Medical Instruments Co, Huang and KDL China.
Improving medical device regulation, growing incidence number of contagious and non-contagious diseases, increasing prevalence of diabetes, and increasing inclination towards home healthcare are escalating the growth of market. Despite these drivers, Risk Associated with blood transfusion may hamper the growth of market.
The global lancet market is expected to reach USD 2,882.6 million by 2022 at a CAGR of 11.3% during the forecasted period.
On the basis of type, market is segmented into Personal Lancet, and Safety Lancet. Safety lancet is further segmented into push button safety lancets, pressure activated safety lancets, and side button safety lancets. Safety Lancets segment accounted for the largest market share of 69.6% during the forecasted period.
On the basis of end-users, market is segmented into Hospitals & clinics, diagnostic centers and pathology laboratories, home diagnostics, and others. Hospitals & Clinics market is expected to grow at a CAGR of 12.1 % from 2016 to 2022.
On the basis of regions, the market is segmented into North America, Europe, Asia-Pacific and the Middle East & Africa. Europe captured a largest market share of around 43.6% in 2015 globally. The lancet market for Europe is estimated at USD 660.1 million in 2016 and expected to reach by USD 1,264.2 million by 2022 at a CAGR of 11.4%.
1 Report Prologue
2 Market Introduction
2.1 Introduction
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
4 Market Dynamics
4.1 Drivers
4.1.1 Improving Medical Device Regulation
4.1.2 Growing incidence number of contagious and non-contagious diseases
4.1.3 Increasing prevalence of diabetes
4.1.4 Increasing inclination towards home healthcare
4.2 Restrains
4.2.1 Risk Associated with blood transfusion
5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Bargaining power of suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Supply Chain Analysis
6 Global Lancet Market, By Type
6.1 Safety lancet
6.3 Personal Lancet
7 Global Lancet Market, By End Users
7.1 Hospitals & Clinics
7.2 Diagnostic Centers and Pathology Laboratories
7.3 Home Diagnostics
7.4 Others
8 Global Lancet Market, By Regions
8.1 North America
8.2 Europe
8.3 Asia Pacific
8.4 Middle East & Africa
9 Competitive Landscape
9.1 Pricing of Lancets
9.2 Production Capacity of Major Players
10 Company Profile
10.1 F. Hoffmann-La Roche AG
10.1.1 Overview
10.1.2 Product/Business Segment Overview
10.1.3 Financial Updates
10.1.4 Key Developments
10.2 Becton, Dickinson and Company
10.2.1 Overview
10.2.2 Product/Business Segment Overview
10.2.3 Financial Updates
10.2.4 Key Developments
10.3 Greiner Bio One International GmbH
10.3.1 Overview
10.3.2 Product/Business Segment Overview
10.3.3 Financial Updates
10.4 Improve Medical Technology Co. Ltd
10.4.1 Overview
10.4.2 Product/Business Segment Overview
10.4.3 Financial Updates
10.5 Terumo Medical Corporation
10.5.1 Overview
10.5.2 Product/Business Segment Overview
10.5.3 Financial Updates
10.5.4 Key Developments
10.6 Bayer Cropscience Limited
10.6.1 Overview
10.6.2 Product/Business Segment Overview
10.6.3 Financial Updates
10.6.4 Key Developments
10.7 HTL-STREFA S.A.
10.7.1 Company Overview
10.7.2 Product/Business Segment Overview
10.7.3 Financial Updates
10.7.4 Key Development
10.8 Sarstedt AG & Co.
10.8.1 Overview
10.8.2 Product/Business Segment Overview
10.8.3 Financial Overview
11 Bibliography
TABLE 1 GLOBAL LANCET MARKET, BY TYPE US$ MILLION 21
TABLE 2 NORTH AMERICA LANCET MARKET, BY TYPE US$ MILLION 22
TABLE 3 US LANCET MARKET, BY TYPE US$ MILLION 23
TABLE 4 CANADA LANCET MARKET, BY TYPE US$ MILLION 24
TABLE 5 EUROPE LANCET MARKET, BY TYPE US$ MILLION 25
TABLE 6 GERMANY LANCET MARKET BY TYPE US$ MILLION 26
TABLE 7 FRANCE LANCET MARKET, BY TYPE US$ MILLION 26
TABLE 8 UK LANCET MARKET, BY TYPE US$ MILLION 27
TABLE 9 ITALY LANCET MARKET, BY TYPE US$ MILLION 28
TABLE 10 POLAND LANCET MARKET, BY TYPE US$ MILLION 28
TABLE 11 REST OF EUROPE LANCET MARKET, BY TYPE US$ MILLION 29
TABLE 12 ASIA PACIFIC LANCET MARKET, BY TYPE US$ MILLION 30
TABLE 13 JAPAN LANCET MARKET, BY TYPE US$ MILLION 31
TABLE 14 CHINA LANCET MARKET, BY TYPE US$ MILLION 31
TABLE 15 INDIA LANCET MARKET, BY TYPE US$ MILLION 32
TABLE 16 SOUTH KOREA LANCET MARKET, BY TYPE US$ MILLION 33
TABLE 17 REST OF ASIA-PACIFIC LANCET MARKET, BY TYPE US$ MILLION 33
TABLE 18 MIDDLE EAST & AFRICA LANCET MARKET, BY TYPE US$ MILLION 34
TABLE 19 UAE LANCET MARKET, BY TYPE US$ MILLION 35
TABLE 20 EGYPT LANCET MARKET, BY TYPE US$ MILLION 35
TABLE 21 SAUDI ARABIA LANCET MARKET, BY TYPE US$ MILLION 36
TABLE 22 REST OF MIDDLE EAST AND AFRICA LANCET MARKET, BY TYPE US$ MILLION 37
TABLE 23 GLOBAL LANCET MARKET, BY END USERS US$ MILLION 39
TABLE 24 US LANCET MARKET, BY END USERS US$ MILLION 41
TABLE 25 CANADA LANCET MARKET, BY END USERS US$ MILLION 41
TABLE 26 EUROPE LANCET MARKET, BY END USERS US$ MILLION 42
TABLE 27 GERMANY LANCET MARKET, BY END USERS US$ MILLION 43
TABLE 28 FRANCE LANCET MARKET, BY END USERS US$ MILLION 43
TABLE 29 UK LANCET MARKET, BY END USERS US$ MILLION 44
TABLE 30 ITALY LANCET MARKET, BY END USERS US$ MILLION 44
TABLE 31 POLAND LANCET MARKET, BY END USERS US$ MILLION 45
TABLE 32 REST OF EUROPE LANCET MARKET, BY END USERS US$ MILLION 45
TABLE 33 ASIA PACIFIC LANCET MARKET, BY END USERS US$ MILLION 46
TABLE 34 JAPAN LANCET MARKET, BY END USERS US$ MILLION 47
TABLE 35 CHINA LANCET MARKET, BY END USERS US$ MILLION 47
TABLE 36 INDIA LANCET MARKET, BY END USERS US$ MILLION 48
TABLE 37 SOUTH KOREA LANCET MARKET, BY END USERS US$ MILLION 48
TABLE 38 REST OF ASIA-PACIFIC LANCET MARKET, BY END USERS US$ MILLION 49
TABLE 39 MIDDLE EAST & AFRICA LANCET MARKET, BY END USERS US$ MILLION 49
TABLE 40 UAE LANCET MARKET, BY END USERS US$ MILLION 50
TABLE 41 EGYPT LANCET MARKET, BY END USERS US$ MILLION 51
TABLE 42 SAUDI ARABIA LANCET MARKET, BY END USERS US$ MILLION 51
TABLE 43 REST OF MIDDLE EAST AND AFRICA LANCET MARKET, BY END USERS US$ MILLION 52
TABLE 44 GLOBAL LANCET MARKET BY REGION US$ MILLION 54
TABLE 45 GLOBAL LANCET MARKET, BY REGION VOLUME (MILLIONS) 55
TABLE 46 NORTH AMERICA LANCET MARKET, BY COUNTRY US$ MILLION 55
TABLE 47 NORTH AMERICA LANCET MARKET, BY COUNTRY VOLUME (MILLION) 56
TABLE 48 EUROPE LANCET MARKET, BY COUNTRY US$ MILLION 57
TABLE 49 EUROPE LANCET MARKET, BY COUNTRY VOLUME (MILLION) 58
TABLE 50 ASIA PACIFIC LANCET MARKET, BY COUNTRY US$ MILLION 58
TABLE 51 ASIA PACIFIC LANCET MARKET, BY COUNTRY (VOLUME) 59
TABLE 52 MIDDLE EAST & AFRICA LANCET MARKET, BY COUNTRY US$ MILLION 60
TABLE 53 MIDDLE EAST & AFRICA LANCET MARKET, BY COUNTRY (VOLUME) 61
TABLE 54 LANCET PRICE INFORMATION 63
TABLE 55 HTL-STREFA S.A.: FINANCIAL REVENUE 77
FIGURE 1 FDA TIME LINE FOR LANCETS 10
FIGURE 2 RESEARCH PROCESS 14
FIGURE 3 PORTERS FIVE FORCES MODEL 18
FIGURE 4 SUPPLY CHAIN ANALYSIS 20
FIGURE 5 GLOBAL LANCET MARKET, BY TYPE 22
FIGURE 6 NORTH AMERICA LANCET MARKET, BY TYPE 23
FIGURE 7 EUROPE LANCET MARKET, BY TYPE 25
FIGURE 8 ASIA PACIFIC LANCET MARKET, BY TYPE 30
FIGURE 9 MIDDLE EAST & AFRICA LANCET MARKET, BY BLOOD LANCET 34
FIGURE 10 GLOBAL LANCET MARKET BY END USERS 38
FIGURE 11 GLOBAL LANCET MARKET, BY END USERS MARKET SHARE 2015 39
FIGURE 12 NORTH AMERICA LANCET MARKET, BY END USERS MARKET SHARE 2015 40
FIGURE 13 EUROPE LANCET MARKET, BY END USERS MARKET SHARE 2015 42
FIGURE 14 ASIA PACIFIC LANCET MARKET, BY END USERS MARKET SHARE 2015 46
FIGURE 15 MIDDLE EAST & AFRICA LANCET MARKET, BY END USERS MARKET SHARE 2015 50
FIGURE 16 GLOBAL LANCET MARKET, BY REGION MARKET SHARE 2015 54
FIGURE 17 NORTH AMERICA LANCET MARKET, BY COUNTRY MARKET SHARE 2015 56
FIGURE 18 EUROPE LANCET MARKET, BY COUNTRY MARKET SHARE 2015 57
FIGURE 19 ASIA PACIFIC LANCET MARKET, BY COUNTRY MARKET SHARE 2015 59
FIGURE 20 MIDDLE EAST & AFRICA LANCET MARKET, BY COUNTRY MARKET SHARE 2015 60
FIGURE 21 GLOBAL LANCET MARKET, MARKET SHARE ANALYSIS 2015 (%) 62
FIGURE 22 F. HOFFMANN-LA ROCHE AG: FINANCIAL REVENUE 65
FIGURE 23 F. HOFFMANN-LA ROCHE AG: SEGMENTAL REVENUE 65
FIGURE 24 BECTON, DICKINSON AND COMPANY: FINANCIAL REVENUE 67
FIGURE 25 BECTON, DICKINSON AND COMPANY: SEGMENTAL REVENUE 68
FIGURE 26 BECTON, DICKINSON AND COMPANY: GEOGRAPHICAL REVENUE 68
FIGURE 27 TERUMO: FINANCIAL REVENUE 72
FIGURE 28 TERUMO: SEGMENTAL REVENUE 73
FIGURE 29 TERUMO: GEOGRAPHICAL REVENUE 73
FIGURE 30 BAYER CROPSCIENCE: FINANCIAL REVENUE 74
FIGURE 31 BAYER CROPSCIENCE: SEGMENTAL REVENUE 75
FIGURE 32 BAYER CROPSCIENCE: GEOGRAPHICAL REVENUE 75
